Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wu-Ling San and Yin-Chen Wu-Ling San for Hyperuricemia
NCT04144088Phase 2Completed
- Sponsor
- Chung Shan Medical University
- Start
- Jun 2006
- Primary completion
- Jun 2007
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
Phase 2, randomised, double-blind trial of oreongsan and Yin Chen Wu Ling San in hyperuricemia (3 arms), sponsored by Chung Shan Medical University. Primary endpoint: Proportion of participants with Serum Uric Acid < 6 mg/dL at 4 weeks. Started Jun 2006; status: completed.
02
Drugs
oreongsanYin Chen Wu Ling San
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT04144088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04144088.